...
首页> 外文期刊>Journal of vascular and interventional radiology: JVIR >The cannon catheter--a prospective analysis.
【24h】

The cannon catheter--a prospective analysis.

机译:大炮导管-前瞻性分析。

获取原文
获取原文并翻译 | 示例

摘要

Clinical outcomes associated with hemodialysis catheters often depend on correct tip positioning. Improper positioning of the catheter tips can reduce blood flow and lead to long-term complications. The authors evaluated the clinical performance of the Arrow Cannon II Plus hemodialysis catheter (Teleflex Medical, Research Triangle Park, North Carolina), a catheter that was designed for tip-first (retrograde) placement to ensure accurate central positioning in the right atrium for optimal flow and minimal recirculation. This 6-month prospective analysis found that the catheter provided high blood flow rates (maximum flow, 410.9-to 430.4 mL/min; mean flow, 378.9-402.4 mL/min) with recirculation rates well below the Kidney Disease Outcomes Quality Initiative (KDOQI) limit (3.6% to 0%). In summary, the Arrow Cannon II Plus hemodialysis catheter was associated with high blood flow rates and minimal complications. Tip-first placement of this novel device represents an important advancement in vascular access for high-performance hemodialysis.
机译:与血液透析导管相关的临床结果通常取决于正确的针头位置。导管尖端放置不当会减少血液流动并导致长期并发症。作者评估了Arrow Cannon II Plus血液透析导管(北卡罗来纳州研究三角公园,Teleflex Medical)的临床性能,该导管设计用于尖端优先(逆行)放置,​​以确保在右心房中进行准确的中央定位,从而获得最佳效果流量和最小的再循环。这项为期6个月的前瞻性分析发现,导管提供的高血流速度(最大流量为410.9至430.4 mL / min;平均流量为378.9-402.4 mL / min),再循环率远低于《肾脏疾病结果质量倡议》(KDOQI) )上限(3.6%到0%)。总之,Arrow Cannon II Plus血液透析导管与高血流速度和最小的并发症相关。尖端放置此新型设备代表了高性能血液透析在血管通路方面的重要进步。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号